Financials Shanghai Aladdin Biochemical Technology Co.,Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 03:30:00 26/06/2024 am IST			5-day change	1st Jan Change
9.91 ^CNY	+3.12%		-3.13%	-27.59%

24/06	Shanghai Aladdin Biochemical Technology Co.,Ltd.(XSSC:688179) dropped from S&P Global BMI Index	CI
08/06	Shanghai Aladdin Biochemical Technology Co.,Ltd. announces an Equity Buyback for CNY 15 million worth of its shares.	CI

Fiscal Period: December	2022	2023	2024	2025	2026
Capitalization ¹	5,108	3,796	2,749	-	-
Enterprise Value (EV) ¹	5,108	3,796	2,749	2,749	2,749
P/E ratio	54 x	39.9 x	11.1 x	8.62 x	-
Yield	-	-	-	-	-
Capitalization / Revenue	-	9.42 x	5.37 x	4.16 x	3.44 x
EV / Revenue	-	9.42 x	5.37 x	4.16 x	3.44 x
EV / EBITDA	-	30.2 x	21.3 x	16.1 x	12.9 x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Price to Book	-	3.66 x	2.52 x	2.31 x	2.1 x
Nbr of stocks (in thousands)	2,76,961	2,77,382	2,77,384	-	-
Reference price ²	18.44	13.69	9.910	9.910	9.910
Announcement Date	27/02/23	24/02/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026
Net sales ¹	-	402.9	512	661	800
EBITDA ¹	-	125.7	129	171	213
EBIT ¹	-	95.2	140	196	242
Operating Margin	-	23.63%	27.34%	29.65%	30.25%
Earnings before Tax (EBT)	-	-	-	-	-
Net income ¹	95.38	85.83	177.1	227.6	-
Net margin	-	21.3%	34.59%	34.44%	-
EPS ²	0.3418	0.3429	0.8929	1.150	-
Free Cash Flow	-	-	-	-	-
FCF margin	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-
Dividend per Share	-	-	-	-	-
Announcement Date	27/02/23	24/02/24	-	-	-

¹CNY in Million²CNY

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-
Net Cash position	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-
Free Cash Flow	-	-	-	-	-
ROE (net income / shareholders' equity)	-	9.27%	11.8%	13.4%	13.6%
ROA (Net income/ Total Assets)	-	5.57%	7.2%	8.3%	9.5%
Assets ¹	-	1,541	2,460	2,742	-
Book Value Per Share ²	-	3.740	3.930	4.290	4.720
Cash Flow per Share	-	-	-	-	-
Capex ¹	-	45.7	90	63	54
Capex / Sales	-	11.34%	17.58%	9.53%	6.75%
Announcement Date	27/02/23	24/02/24	-	-	-

¹CNY in Million²CNY

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

9.91 CNY

Average target price

12.14 CNY

Spread / Average Target

+22.53%

	1st Jan change	Capi.
SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.	-27.59%	367M
MODERNA, INC.	+23.13%	52.73B
LONZA GROUP AG	+37.49%	39B
IQVIA HOLDINGS INC.	-8.73%	38.52B
ALNYLAM PHARMACEUTICALS, INC.	+28.09%	30.38B
CELLTRION, INC.	-12.26%	26.39B
ICON PUBLIC LIMITED COMPANY	+10.57%	26.08B
UNITED THERAPEUTICS CORPORATION	+45.05%	14.15B
MEDPACE HOLDINGS, INC.	+32.23%	12.6B
BIO-TECHNE CORPORATION	-6.56%	11.51B